With the concurrent launch this week of the new version of its horizontal DecisionSite platform as well as a pre-configured DecisionSite for Functional Genomics, Spotfire is pushing ahead with its goal of meeting the broad range of analytical needs along the discovery pipeline. David Butler, vice president of product strategy and marketing at Spotfire, said the company hopes to see DecisionSite used along the key processes of the entire enterprise — from product development to supply chain management, manufacturing, finance, and performance management.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.